Zuleger, Cindy L <br/><br/>
In vivo 6-thioguanine-resistant T cells from melanoma patients have public TCR and share TCR beta amino acid sequences with melanoma-reactive T cells.  [electronic resource] 

 -  Journal of immunological methods  Feb 2011 
 - 76-86 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1872-7905 
<br/><br/><label>Standard No.: </label>10.1016/j.jim.2010.12.007  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Amino Acid Motifs<br/>Amino Acid Sequence<br/>Antigens, Neoplasm--genetics<br/>Antineoplastic Agents--pharmacology<br/>Biomarkers, Tumor--genetics<br/>Case-Control Studies<br/>Cells, Cultured<br/>Drug Resistance, Neoplasm--genetics<br/>Female<br/>Genes, T-Cell Receptor beta<br/>Humans<br/>Hypoxanthine Phosphoribosyltransferase--deficiency<br/>Lymphocyte Activation<br/>Male<br/>Melanoma--drug therapy<br/>Melanoma-Specific Antigens--genetics<br/>Middle Aged<br/>Molecular Sequence Data<br/>Mutation<br/>Receptors, Antigen, T-Cell, alpha-beta--genetics<br/>T-Lymphocytes--drug effects<br/>Thioguanine--pharmacology